Change your cover photo
Upload
patrick.guiry
This user account status is Approved

This user has not added any information to their profile yet.

Principal Investigator
UCD
Executive Committee Member
Synthetic Organic Chemist; Medicinal Chemist.

2019-present: Vice-President of the Institute of Chemistry of Ireland
2019-present: Elected member of Professorial Panel, UCD Governing Authority
2019: Graduated 48th PhD student.
2018-present: Chair of the Board of the Young Scientist & Technology Limited
2017-present: Member of the Senate of the National University of Ireland
2016-present: Elected Science Secretary of the Royal Irish Academy
2015-2017: President of the European Symposium on Organic Chemistry Scientific Committee
2011-2014: Head of UCD School of Chemistry
2013: Elected a Member of the Royal Irish Academy (MRIA)
2013: Awarded the Boyle-Higgins Medal, Institute of Chemistry of Ireland
2012: Elected a Fellow of the Royal Society of Chemistry (FRSC)

Professor Guiry’s key professional/work interests include the teaching of (organic) chemistry to third and fourth level students, the training of under- and postgraduate students in synthetic chemistry and the supervision of PhD students, visiting international students and postdoctoral researchers.

Pat’s research group focuses on synthetic organic chemistry, with interests / expertise in both the development of asymmetric synthetic methodology through the design and application of new chiral ligands in homogeneous metal-catalysed transformations and in the total synthesis of compounds of biological interest. His programme includes the use of nature as an inspiration for the design and synthesis of a family of stable lipoxin A4 analogues for the resolution of inflammation. Key skills include the structure identification / confirmation of compounds synthesised / isolated through the application of the full breadth of modern spectroscopic and analytical techniques.

Current projects focus on the conversion of waste material from the agri-food industry into higher value chemicals, the employment of CO2 as a C-1 synthon, the design of novel organocatalysts, the synthesis of potential anti-cancer agents and novel anti-inflammatories.